Trump’s $1.5 trillion defense budget includes $750 billion for ships, jets and Golden Dome

The Pentagon unveiled a $1.5 trillion defense budget request for fiscal 2027, including a $1.15 trillion base request and a $350 billion supplemental, the largest year-over-year defense spending increase in the post-WWII era. Key allocations include more than $65 billion for 18 warships and 16 support ships, $102 billion for aircraft procurement and R&D, $53.6 billion for autonomous drone platforms, and $6.1 billion for Northrop Grumman’s B-21 bomber. The plan is broadly supportive for major defense contractors, but near-term funding for the Iran conflict is excluded and would require a separate supplemental request.

Analysis

This is a multi-year demand acceleration story disguised as a one-year budget headline. The key second-order effect is that the Pentagon is moving from episodic procurement to capacity reservation: longer contracts and a larger supplemental pipeline improve visibility for primes, but the bigger beta sits with bottleneck suppliers in shipyards, energetics, avionics, and software integration. In practice, the incremental dollar should translate into more pricing power for the prime contractors only if they can secure labor and subcomponents fast enough; otherwise margins leak down the chain to vendors and shipyard labor rather than equity holders.

Within the named names, the market is likely underestimating how uneven the mix is. Shipbuilders and platform primes with already-constrained capacity should re-rate first because backlog quality improves faster than revenue, while aircraft and bomber exposure is more back-half weighted and more vulnerable to schedule slippage. The drone/autonomy push is the most asymmetric: it is less about far-future R&D and more about converting existing software, sensors, and logistics into funded procurement, which should favor firms with fielded systems and recurring sustainment rather than pure-play concept-stage autonomy names.

The main risk is that the budget headline becomes a financing and timing story rather than a clean earnings story. If the reconciliation process slips or supplemental funding is politically diluted, the market may have to wait several quarters for POs to turn into shipped revenue, which would compress near-term enthusiasm despite strong backlog optics. A second risk is that the defense industrial base can only absorb so much at once; if labor and supplier constraints persist, unit economics could disappoint even as top-line estimates rise.

Consensus is likely too focused on the large primes and not enough on the supply chain leverage created by multi-year awards. The less obvious winner is the ecosystem of qualified subcontractors and testing/integration vendors that can absorb volume without major capex, while the less obvious loser is any prime with the weakest production execution or highest program risk. The market may also be underpricing the probability that this budget sets a new normalized floor for defense spend, which would justify higher valuation bands for the group even before full-year earnings inflect.

Key Decisions for Investors

• Go long GD/HII vs. NOC on a 3-6 month horizon: shipbuilding visibility and capacity scarcity should translate into faster backlog conversion than more R&D-heavy exposure; target 8-12% relative outperformance if appropriations stay intact.
• Buy LMT on any post-headline pullback over the next 1-2 weeks, but size modestly: the mix is supportive, yet F-35/bomber execution risk makes this a slower-burn rerating than the shipbuilders; use a 5-7% stop.
• Pair trade: long defense industrial suppliers / subcontractor exposure, short lower-quality program-heavy primes if available via basket or options, because the next leg is likely margin capture in the supply chain rather than only at the prime level.
• Express the view with call spreads in GD or HII expiring in 3-6 months to capture backlog re-rating while limiting downside if the reconciliation process delays cash flow recognition.
• Avoid chasing NOC here; its lower sensitivity to the budget mix suggests weaker near-term beta versus the other names, making it a funding source for relative-value longs.